Engineered Bacteria Fight Pancreatic Cancer | Science News

Scientists have engineered gut-friendly bacteria to become microscopic drug factories that target pancreatic tumors, showing promising results in animal studies. By modifying Bifidobacterium longum to deliver a potent immune-boosting molecule directly into tumors, the therapy activates cancer-fighting T cells while avoiding systemic side effects. These bacteria naturally seek out the oxygen-poor tumor environment, making them ideal delivery vehicles. When combined with chemotherapy, radiation, or immunotherapy, the treatment significantly improved tumor control and survival rates. Though still in preclinical stages, the approach—part of the emerging “bugs as drugs” movement—offers a novel, potentially safer strategy for one of the toughest cancers to treat. Human trials and oral delivery methods are next on the roadmap. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/1017e0650066a055